Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The Problem with the Share Price

Conversely, when there has been no creation of shareholder value over a number of years and shareholder value has in fact plummeted, it would not be unreasonable to conclude that the officers and directors are likewise responsible

It wouldn't have anything to do with licensing, would it? Perhaps there is a master plan out there by which infringers rush to sign, giving a predictable revenue to underpin a share price without which it continues to languish?

.

.

.

Be well

Share
New Message
Please login to post a reply